Abstract
Two historical cohorts (1993-1994 and 2001) of preterm infants ventilated for respiratory distress syndrome were compared. Dexamethasone administration fell from 22% to 6%. Chronic lung disease in survivors rose slightly from 13% to 17%, and mortality fell from 21% to 15% (other causes). The effect of restriction of dexamethasone use on chronic lung disease and mortality remains to be seen.
Original language | English |
---|---|
Pages (from-to) | F432-F433 |
Journal | Archives of Disease in Childhood: Fetal and Neonatal Edition |
Volume | 88 |
Issue number | 5 |
DOIs | |
State | Published - Sep 2003 |
Externally published | Yes |